HireRight’s U.S.-based COVID-19 screening solutions are designed to provide employers with the tools they need to help mitigate the potential risk of COVID-19 exposure to their employees and customers. We understand that every business is unique with varying operational and risk considerations and a one-size-fits-all approach will not work in today’s diverse working environment.
COVID-19 Viral Marker Tests
HireRight offers simple, self-administered viral marker* tests that can be performed in the safety and security of an employee's home, no need to schedule a clinic or telemedicine visit. The test detects the presence of coronavirus in a saliva sample that is easy to collect and is not "technique dependent".
COVID-19 Self-Assessment Tool Provided by Preworkscreen
A simple and efficient way to conduct pre-shift employee COVID-19 symptom questionnaires. Employees can download the Preworkscreen app for iPhone or Android and complete the self-assessment on-the-go.
Questions are based on current Center for Disease Control and Prevention (CDC) and state specific guidelines where employees are located.
Assessment results are compiled in real-time and immediately available to employers through their Preworkscreen dashboards where they can quickly track and monitor the overall health-statuses of their workforce.
As the country returns to work, employers need to consider how best to decrease the possible spread of COVID-19 in their business and lower the potential impact to their workers and customers. Until a vaccine is readily available on a nationwide basis, risk mitigation tools such as screenings and self-assessments are a good first line of defense.
COVID-19 Viral Marker Tests
*Testing Disclosure: This viral marker test (molecular via RT-PCR) has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by Clinical Reference Laboratory, Inc. located in Lenexa, KS. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3 (b)(1), unless the authorization is terminated or revoked sooner.
COVID-19 Self-Assessment Tool Provided by Preworkscreen**
** The COVID-19 Self-Assessment Tool Provided by Preworkscreen, a HireRight referral partner not affiliated with HireRight, under separate terms and conditions with Preworkscreen.